Literature DB >> 2570420

Mammalian multidrug-resistance gene: correlation of exon organization with structural domains and duplication of an ancestral gene.

M Raymond1, P Gros.   

Abstract

Analysis of the nucleotide and deduced amino acid sequences of the biologically active mouse mdr1 cDNA clone indicates that the protein is formed by two highly homologous halves, each containing six putative transmembrane domains and a nucleotide-binding site. The duplicated unit shows high sequence homology to the proposed energy-coupling subunit of bacterial periplasmic transport proteins. We have cloned and characterized the mouse mdr1 gene and have analyzed the genomic organization of the two homologous halves forming the mdr1 protein. The gene spans 68 kilobases, is split into 28 exons, and the two homologous halves are encoded by 14 and 13 exons. The transcriptional initiation site of the gene has been mapped and putative TATA and consensus CAAT sequences have been found at positions -27 and -83, respectively. Discrete structural domains of the mdr1 protein are encoded by separate exons: Ten of the 12 putative transmembrane domains are encoded by individual exons and the two nucleotide-binding sites are each encoded by three exons. The exon/intron organization of the gene is conserved in the two highly homologous regions encoding the nucleotide-binding sites. The conservation of certain pairs of introns, together with the high degree of sequence homology, indicate that the mouse mdr1 gene originated from the duplication of an intron-containing ancestral gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570420      PMCID: PMC297869          DOI: 10.1073/pnas.86.17.6488

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Domains and the hinge region of an immunoglobulin heavy chain are encoded in separate DNA segments.

Authors:  H Sakano; J H Rogers; K Hüppi; C Brack; A Traunecker; R Maki; R Wall; S Tonegawa
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

2.  Structure and control of phosphofructokinase from Bacillus stearothermophilus.

Authors:  P R Evans; P J Hudson
Journal:  Nature       Date:  1979-06-07       Impact factor: 49.962

3.  The rabbit muscle phosphofructokinase gene. Implications for protein structure, function, and tissue specificity.

Authors:  C P Lee; M C Kao; B A French; S D Putney; S H Chang
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

4.  Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin.

Authors:  J Nathans; D S Hogness
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

5.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

6.  Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells.

Authors:  T Skovsgaard
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

7.  Why genes in pieces?

Authors:  W Gilbert
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

8.  The LDL receptor gene: a mosaic of exons shared with different proteins.

Authors:  T C Südhof; J L Goldstein; M S Brown; D W Russell
Journal:  Science       Date:  1985-05-17       Impact factor: 47.728

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.

Authors:  J E Walker; M Saraste; M J Runswick; N J Gay
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  12 in total

1.  Cell-specific activity of cis-acting regulatory elements in the promoter of the mouse multidrug resistance gene mdr1.

Authors:  M Raymond; P Gros
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  P-glycoprotein structure and evolutionary homologies.

Authors:  I Bosch; J M Croop
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 3.  Genetic basis of multidrug resistance of tumor cells.

Authors:  S E Kane; I Pastan; M M Gottesman
Journal:  J Bioenerg Biomembr       Date:  1990-08       Impact factor: 2.945

4.  Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells.

Authors:  M Raymond; E Rose; D E Housman; P Gros
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

Review 5.  P-glycoprotein structure and evolutionary homologies.

Authors:  J M Croop
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  A bacterial analog of the mdr gene of mammalian tumor cells is present in Streptomyces peucetius, the producer of daunorubicin and doxorubicin.

Authors:  P G Guilfoile; C R Hutchinson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

Review 7.  P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy.

Authors:  S Gupta
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 8.  P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.

Authors:  T Licht; I Pastan; M Gottesman; F Herrmann
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

9.  Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition.

Authors:  Dahea You; Jason R Richardson; Lauren M Aleksunes
Journal:  Drug Metab Dispos       Date:  2020-03-19       Impact factor: 3.922

10.  Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.

Authors:  A Devault; P Gros
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.